News / Events Press Releases IR Calendar Audio and Video Email Alerts All News 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Search terms Number of Published Scientific Papers Citing the Advantages of Pressure BioSciences’ PCT Platform Remained Strong in 2019 Jan 9, 2020 Zacks Small Cap Research Releases Updated Report on Pressure BioSciences, Inc. Dec 30, 2019 Pressure BioSciences, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update Dec 19, 2019 Pressure BioSciences, Inc. to Discuss Third Quarter 2019 Financial Results and Provide Business Update Dec 18, 2019 Zacks Small Cap Research Initiates Coverage on Pressure BioSciences, Inc. Oct 4, 2019 Pressure BioSciences’ Proprietary PCT Platform Fills Pivotal Role for Tumor Analyses in Novel Workflow Presented at Leading Global Gynecologic Cancer Meeting Oct 1, 2019 Pressure BioSciences’ PCT Platform Featured in Multiple Presentations at Major International Science Conference Sep 26, 2019 Pressure BioSciences Prepares for Growth, Adding Daniel J. Shea as Chief Financial Officer Sep 17, 2019 Pressure BioSciences’ PCT Platform Identified as Pivotal for Cancer Biomarker Discovery and for Potential Clinical Diagnostics Sep 10, 2019 Pressure BioSciences Announces Two More Purchase Orders for its Revolutionary BaroShear K45 Processing System for Manufacturing Water-Soluble CBD Aug 22, 2019 1... 5 6 7 8 9 10 11 12 13 14 ...42
Number of Published Scientific Papers Citing the Advantages of Pressure BioSciences’ PCT Platform Remained Strong in 2019 Jan 9, 2020
Pressure BioSciences, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update Dec 19, 2019
Pressure BioSciences, Inc. to Discuss Third Quarter 2019 Financial Results and Provide Business Update Dec 18, 2019
Pressure BioSciences’ Proprietary PCT Platform Fills Pivotal Role for Tumor Analyses in Novel Workflow Presented at Leading Global Gynecologic Cancer Meeting Oct 1, 2019
Pressure BioSciences’ PCT Platform Featured in Multiple Presentations at Major International Science Conference Sep 26, 2019
Pressure BioSciences Prepares for Growth, Adding Daniel J. Shea as Chief Financial Officer Sep 17, 2019
Pressure BioSciences’ PCT Platform Identified as Pivotal for Cancer Biomarker Discovery and for Potential Clinical Diagnostics Sep 10, 2019
Pressure BioSciences Announces Two More Purchase Orders for its Revolutionary BaroShear K45 Processing System for Manufacturing Water-Soluble CBD Aug 22, 2019
